EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) said its board of directors declared a quarterly dividend of $0.22 per share and authorized a new share repurchase program of up to $1 billion.
The dividend was declared February 16 and is payable May 6 to shareholders of record as of April 29, the company said.
The board approved the new share repurchase program on February 17. The company said the timing and number of shares repurchased will depend on factors including stock price, market conditions and regulatory requirements.
West said shares may be repurchased from time to time on the open market, through pre-set trading plans, in privately negotiated transactions or through other methods permitted under securities laws.
The repurchase program does not require the company to buy a specific amount of stock, has no expiration date and may be suspended or terminated at any time, according to the announcement.
The company’s previous repurchase program was fully utilized before its December 31, 2025, expiration.
West Pharmaceutical Services, headquartered in Exton, Pennsylvania, reported net sales of $3.07 billion for fiscal year 2025. The company employs more than 10,000 people across 50 sites worldwide and is a component of the S&P 500 index.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.